Revised Assessment Criteria for Prostigmine Test of Myasthenia Gravis

摘要：

OBJECTIVE: To revise the existing assessment criteria of the Prostigmine Test (PST) in order to establish a more practical diagnostic method for patients with myasthenia gravis (MG).METHODS: One hundred and two adult patients with confirmed MG and 97 normal controls were enrolled.All subjects received prostigmine 1.5 mg (about 0.02 mg/kg) and atropine 1.0 mg intramuscular injection (0.01-0.015 mg/kg).

作者: D.T.Peng Z.H.Wang X.H.Zhang X.H.Xu

作者单位: Department of Neurology, China-Japan Friendship Hospital, Ministry of Health, Beijing;Chinese Center for Disease Control and Prevention;Department of Neurology, Tiantan Hospital;Department of Neurology, Beijing Hospital, Ministry of Health

会议类型: 国内会议

会议名称: 2015中国老年医学和老年健康产业大会

会议地点: 苏州

会议语种:英文

页码: 377-377

在线出版日期: 2015-09-11（万方平台首次上网日期，不代表论文的发表时间）